Clinical Trials
6 trialsNCT06363123 2024-04-15
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Unknown
NCT05311618 2024-04-01
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
Phase 1 Unknown
NCT05872867 2024-03-12
MK-3475-E90
Wellmarker Bio
Phase 1 Unknown
NCT03924466 2024-02-16
VUBAR
Universitair Ziekenhuis Brussel
Phase 2 Unknown
NCT04801095 2022-09-16
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Wellmarker Bio
Phase 1 Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown